Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
28,234,434
-
Total 13F shares
-
9,158,528
-
Share change
-
+1,209,069
-
Total reported value
-
$109,328,754
-
Put/Call ratio
-
40%
-
Price per share
-
$11.94
-
Number of holders
-
96
-
Value change
-
+$14,491,053
-
Number of buys
-
62
-
Number of sells
-
47
Institutional Holders of ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) as of Q2 2025
As of 30 Jun 2025 ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) had 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 9,158,528 shares of stock of the company.
Largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, MORGAN STANLEY, BROWN ADVISORY INC, ESSEX INVESTMENT MANAGEMENT CO LLC, D. E. Shaw & Co., Inc., GOLDMAN SACHS GROUP INC, and Lane Generational LLC.
This table shows 96 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.